LONG-LASTING EX-VIVO INHIBITION BY PERINDOPRIL OF RAT VASCULAR-RESPONSE TO ANGIOTENSIN-I

被引:0
作者
ISHIGAI, Y [1 ]
FUKUZAWA, A [1 ]
CHIBA, K [1 ]
IRIE, K [1 ]
SHIBANO, T [1 ]
机构
[1] DAIICHI PHARMACEUT CO LTD,TOKYO RES & DEV CTR,EXPLORATORY RES LABS 2,EDOGAWA KU,TOKYO 134,JAPAN
来源
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 1994年 / 16卷 / 09期
关键词
ANGIOTENSIN-CONVERTING ENZYME; ANGIOTENSIN I; AORTA; PERFUSED HEART; PERINDOPRIL; ENALAPRIL;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ex vivo effects of perindopril and enalapril, inhibitors of angiotensin-converting enzyme (ACE), were studied on rat aortae and perfused hearts to clarify the inhibition of vascular response to angiotensin I. The duration of the effects of these inhibitors was also studied One hour after oral administration of perindopril (0.1-30 mg/kg) or enalapril (0.3-100 mg/kg), the aortae and hearts were isolated for the measurement of isometric force and coronary flow, respectively. In aortae, perindopril and enalapril dose-dependently inhibited the maximal contractions to angiotensin I(1-1000 nM). In isolated perfused hearts, the compounds inhibited the decrease in coronary flow induced by angiotensin I(100 ng). In other experiments, the inhibitory effects of perindopril lasted for 24 h in both aortae (3 mg/kg, p.o.) and hearts (10 mg/kg, p.o.). In contrast, the effects of enalapril disappeared within 6 h in aortae (3 mg/kg, p.o.) and 12 h in hearts (100 mg/kg, p.o.). These results demonstrate that oral administration of ACE inhibitors reduce the ex vivo vascular response to angiotensin I and suggest that perindopril is a longer-lasting inhibitor than enalapril on vascular contraction to locally generated angiotensin II.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 21 条
  • [1] PHARMACOKINETIC OPTIMIZATION OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR THERAPY
    BURNIER, M
    BIOLLAZ, J
    [J]. CLINICAL PHARMACOKINETICS, 1992, 22 (05) : 375 - 384
  • [2] LACK OF CORRELATION OF HYPOTENSIVE EFFECTS WITH PREVENTION OF CARDIAC-HYPERTROPHY BY PERINDOPRIL AFTER LIGATION OF RAT CORONARY-ARTERY
    CHIBA, K
    MORIYAMA, S
    ISHIGAI, Y
    FUKUZAWA, A
    IRIE, K
    SHIBANO, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) : 837 - 842
  • [3] DEAMEN M, 1991, CIRC RES, V68, P450
  • [4] COMPARISON OF THE ACTIONS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ENALAPRIL AND S-9490-3 IN SODIUM-DEPLETE AND SODIUM-REPLETE SPONTANEOUSLY HYPERTENSIVE RATS
    DINICOLANTONIO, R
    DOYLE, AE
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (05) : 937 - 942
  • [5] EMERGING ROLE OF THE TISSUE RENIN-ANGIOTENSIN SYSTEMS IN CONGESTIVE HEART-FAILURE
    DZAU, VJ
    HIRSCH, AT
    [J]. EUROPEAN HEART JOURNAL, 1990, 11 : 65 - 71
  • [6] DZAU VJ, 1984, J HYPERTENSION S3, V2, P235
  • [7] SIGNIFICANCE OF VASCULAR RENIN FOR LOCAL GENERATION OF ANGIOTENSINS
    HIGASHIMORI, K
    GANTE, J
    HOLZEMANN, G
    INAGAMI, T
    [J]. HYPERTENSION, 1991, 17 (03) : 270 - 277
  • [8] DIFFERENTIAL-EFFECTS OF CAPTOPRIL AND ENALAPRIL ON TISSUE RENIN-ANGIOTENSIN SYSTEMS IN EXPERIMENTAL HEART-FAILURE
    HIRSCH, AT
    TALSNESS, CE
    SMITH, AD
    SCHUNKERT, H
    INGELFINGER, JR
    DZAU, VJ
    [J]. CIRCULATION, 1992, 86 (05) : 1566 - 1574
  • [9] TISSUE-SPECIFIC ACTIVATION OF CARDIAC ANGIOTENSIN CONVERTING ENZYME IN EXPERIMENTAL HEART-FAILURE
    HIRSCH, AT
    TALSNESS, CE
    SCHUNKERT, H
    PAUL, M
    DZAU, VJ
    [J]. CIRCULATION RESEARCH, 1991, 69 (02) : 475 - 482
  • [10] JACKSON B, 1988, J HYPERTENS, V6, pS51